10/31/14 BABY 34.00 Natus Medical Inc $BABY Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
10/31/14 BABY 34.00 Natus Medical Inc $BABY Hit a 52 week high of 35.05 Closing the day 10/31/14 at 34.00 +0.13 +0.38% With a day low of 33.83 and a total volume of 493,700.

BABY Recent Posts: http://investorshangout.com/Natus-Medical-Inc-BABY-53443/

BABY Natus Medical Inc Recent Headline News

Sleep Apnea Diagnostic and Therapeutic Devices - 2014 Global Strategic Business Report
M2 - Thu Oct 30, 6:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qbnnd7/sleep_apnea) has announced the addition of the "Sleep Apnea Diagnostic and Therapeutic Devices - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 71 companies including many key and niche players such as: - Cadwell Laboratories, Inc. - CareFusion Corporation - Cleveland Medical Devices, Inc. - Compumedics Ltd. - DeVilbiss Healthcare - Global Medical Holdings LLC - Fisher & Paykel Healthcare Limited - GE Healthcare - Itamar Medical Ltd. - Invacare Corporation - Natus Medical Inc. - Embla Systems, Inc. - Grass Technologies - Philips Healthcare - ResMed Inc. - Teleflex Medical - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends And Dynamics 3. Sleep Apnea - A Synopsis 4. Sleep Apnea Diagnostic And Therapeutic Devices 5. Research Findings In Recent Past 6. Product Launches/Introductions 7. Recent Industry Activity 8. Focus On Select Players 9. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Middle East And Africa IV. Competitive Landscape Total Companies Profiled: 71 (including Divisions/Subsidiaries - 76) - The United States (48) - Canada (4) - Japan (1) - Europe (12) - - Germany (3) - - The United Kingdom (2) - - Italy (2) - - Spain (2) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (8) - Middle East (3) For more information visit http://www.researchandmarkets.com/research/qb...leep_apnea
BABY: 34.00 (+0.13), IVC: 15.71 (+0.01), RMD: 52.22 (+0.11)

Shares of BABY Up 28.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 29, 4:49PM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 6 months, Natus Medical has returned 28.94% as of today's recent price of $33.64.
BABY: 34.00 (+0.13)

Edwards Lifesciences (EW) Worth Watching: Stock Up 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:25AM CDT
Edwards Lifesciences (EW) was a big mover last session, with shares rising 11% on the day.
BABY: 34.00 (+0.13), PACB: 6.56 (-0.06), EW: 120.92 (+0.64), ANGO: 17.00 (+0.15)

Is Natus Medical (BABY) a Great Growth Stock? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 7:53AM CDT
If you are looking for a fast growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Natus Medical.
BABY: 34.00 (+0.13)

3 Momentum Stocks to Watch in Biotechnology for Continued Upside
at The Street - Thu Oct 23, 2:39PM CDT
Wednesday was a strong session for a number of stocks, and here are three, in particular, to watch for more upside.
BABY: 34.00 (+0.13), RGLS: 19.96 (+1.66), AGIO: 84.03 (-0.34)

Natus Medical Rises 1.71% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Oct 22, 5:38PM CDT
Natus Medical (NASDAQ:BABY) traded in a range yesterday that spanned from a low of $31.06 to a high of $33.20. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $32.44 on volume of 863,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BABY: 34.00 (+0.13)

Natus Medical Inc. Hears Higher Margins Calling
Brian Orelli, The Motley Fool - Motley Fool - Wed Oct 22, 1:53PM CDT
Organic revenue growth of 5% is nothing to get too excited about, but increasing margins made for a nice bottom-line improvement at Natus Medical . Non-GAAP net income increased 16.5% year over year in the third quarter to $10.6 million.  Gross...
BABY: 34.00 (+0.13)

Natus Medical Shares Up 19.4% Since SmarTrend's Buy Recommendation (BABY)
Comtex SmarTrend(R) - Wed Oct 22, 11:05AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 6 months, Natus Medical has returned 19.39% as of today's recent price of $31.15.
BABY: 34.00 (+0.13)

Natus Medical tops Street 3Q forecasts
Automated Insights - Wed Oct 22, 6:57AM CDT
SAN CARLOS, Calif. (AP) _ Natus Medical Inc. (BABY) on Wednesday reported earnings of $7.8 million in its third quarter.
BABY: 34.00 (+0.13)

Natus Medical Announces Record Third Quarter and Year-to-Date 2014 Financial Results
GlobeNewswire - Wed Oct 22, 6:04AM CDT
-- Reports organic revenue growth of 5% for the third quarter
BABY: 34.00 (+0.13)

Don't Miss Today's Strong And Under The Radar Stock: Natus Medical (BABY)
at The Street - Tue Oct 21, 8:51AM CDT
Trade-Ideas LLC identified Natus Medical (BABY) as a strong and under the radar candidate
BABY: 34.00 (+0.13)

Natus Medical Announces First of Kind Vista Ultrasound System
GlobeNewswire - Thu Oct 16, 6:00AM CDT
Natus Medical Incorporated (Nasdaq:BABY) today announced the launch of the Vista Ultrasound System. The Vista Ultrasound System is the first product in the market to enable the use of Ultrasound with an EMG workstation. The Vista Ultrasound System adds ultrasound capability to Natus' market leading EDX and UltraPro S100 EMG workstations. The new Vista Ultrasound System will be available worldwide.
BABY: 34.00 (+0.13)

Shares of BABY Up 14.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 15, 9:53AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 6 months, Natus Medical has returned 14.67% as of today's recent price of $29.92.
BABY: 34.00 (+0.13)

4 Stocks Rising on Big Volume to Trade for Breakouts
at The Street - Mon Oct 13, 6:53AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
ZUMZ: 33.38 (-0.49), ECOL: 50.28 (+0.18), BABY: 34.00 (+0.13), ANGO: 17.00 (+0.15)

Natus Medical Up 17.2% Since SmarTrend Uptrend Call (BABY)
Comtex SmarTrend(R) - Wed Oct 08, 9:18AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 6 months, Natus Medical has returned 17.25% as of today's recent price of $30.59.
BABY: 34.00 (+0.13)

Natus Medical to Hold 2014 Third Quarter Financial Results Conference Call on October 22nd
GlobeNewswire - Wed Oct 08, 6:00AM CDT
Natus Medical Incorporated (Nasdaq:BABY) today announced that the Company will release its 2014 third quarter financial results before the market opens on Wednesday, October 22. Natus management will host an investment-community conference call the same day beginning at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to discuss those results and to answer questions.
BABY: 34.00 (+0.13)

Upgrade Alert for Natus Medical (BABY)
Comtex SmarTrend(R) - Tue Oct 07, 6:55AM CDT
Natus Medical (NASDAQ:BABY) was upgraded from Market Perform to Outperform at William Blair today. The stock closed yesterday at $30.76 on volume of 412,000 shares, above average daily volume of 218,000. In the past 52 weeks, Natus Medical share prices have been bracketed by a low of $13.55 and a high of $31.70 and closed yesterday at $30.76, 127% above that low price. The 200-day and 50-day moving averages have moved 0.54% higher and 0.68% higher over the past week, respectively.
BABY: 34.00 (+0.13)

Technology Stocks Slide But Other Sectors Hold Up Better
at Investor's Business Daily - Thu Sep 25, 5:55PM CDT
A harsh sell-off in the market Thursday did not spare many stocks in Your Weekly Review. Nearly every stock on the screen closed lower, and the selling affected certain sectors more than others. However, few leaders triggered outright sell signals....
AMBA: 44.29 (+2.49), MNST: 100.88 (+1.78), BIIB: 321.08 (+0.08), CAVM: 51.31 (+1.68), HD: 97.52 (unch), CNW: 43.37 (+1.02), ARUN: 21.58 (+0.58), STZ: 91.54 (+2.13), NXPI: 68.66 (+3.25), CELG: 107.09 (+0.15), BABY: 34.00 (+0.13), JAZZ: 168.84 (-0.98), ALXN: 191.36 (-1.57), HBI: 105.61 (-1.04), AAPL: 108.00 (+1.02), AVGO: 86.25 (+3.86)

9.5% Return Seen to Date on SmarTrend Natus Medical Call (BABY)
Comtex SmarTrend(R) - Tue Sep 23, 11:09AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 5 months, Natus Medical has returned 9.54% as of today's recent price of $28.58.
BABY: 34.00 (+0.13)

Natus Medical Inc. (NTUS) Stock Research Links

NTUS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 272

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 238

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 12

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 315

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 286

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 83

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 110

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 183

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 0

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading

Top 5 Most Recently Viewed Articles

Anytime Fitness Launches First Club in Dubai, UAE, Expanding Reach

Updated Category News Views 508

Anytime Fitness Sets Foot in Dubai with Grand Opening The new club in the Arjan district signifies a vital expansion of fitness services to the United Arab Emirates; members benefit from personalized wellness plans, state-of-the-art Technogym equipment, and SmartCoaching services available through the AF App. Purpose Brands LLC has announced the grand opening of its very...

Continue Reading
Crescent Biopharma's Strategic Partnership and Market Moves

Updated Category News Views 196

Crescent Biopharma's Recent Stock Activity Crescent Biopharma, Inc. (NASDAQ: CBIO) has been experiencing a notable fluctuation in its stock value lately. Shares initially showed a positive trend, indicating investor optimism following their recent announcement, but later reversed course and began to dip slightly. This change in trading comes as the company unveiled a...

Continue Reading
Investors Alert: Legal Developments for Snap Inc. Shareholders

Updated Category News Views 167

Important Update for Snap Inc. Shareholders If you have invested in Snap Inc. (NYSE: SNAP) and purchased shares in 2021 or earlier, there are significant legal developments that you should be aware of. A recent lawsuit is reportedly pending, and the Shareholders Foundation has urged impacted investors to take action. Details of the Lawsuit Against Snap Inc. The lawsuit...

Continue Reading
Understanding the Influence of Trump's Fiscal Policies on Debt

Updated Category News Views 493

Understanding the Influence of Trump's Fiscal Policies on Debt When it comes to government debt, being large isn't necessarily an advantage. Recent fiscal policies introduced by the Trump administration, including tariffs and the initiatives of the Department of Government Efficiency, aim to address the growing fiscal deficit. However, the overall effect may result in...

Continue Reading
Analyzing Sea's Short Interest Trends and Market Implications

Updated Category News Views 128

Understanding Sea's Short Interest Dynamics Sea's short percent of float has notably increased by 5.22% since the latest report. The company currently has 21.99 million shares sold short, which accounts for 7.46% of its total shares available for trading. Based on recent trading volumes, it would take an average of 5.24 days for traders to cover their short positions....

Continue Reading